Consumers appropriately self-treat based on labeling for over-the-counter hydrocortisone

Journal of the American Academy of Dermatology

Volumn 53, Issue 1, 2005, Pages 41-51

  Ellis, Charles N ^a   Pillitteri, Janine L ^b   Kyle, Theodore K ^c   Ertischek, Michelle D ^b   Burton, Steven L ^c   Shiffman, Saul ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b PINNEY ASSOCIATES   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; CORTICOSTEROID; CORTIZONE; HYDROCORTISONE; HYDROCORTISONE ACETATE; NON PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONSUMER; CONTROLLED STUDY; DRUG LABELING; DRUG POTENCY; ECZEMA; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; INSECT BITE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RASH; SELF MEDICATION; SIDE EFFECT; TELEPHONE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG LABELING; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF MEDICATION;

EID: 20444443412     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.01.107     Document Type: Article

References (21)

1. US Department of Health and Human Services. Handout on Health. Atopic dermatitis (A type of eczema). National Institute of Arthritis and Musculoskeletal and Skin Diseases. April 2003. Available at: http://www.niams.nih.gov/hi/topics/dermatitis/AtopicDerm.pdf. Accessed April 20, 2004.
2. National Psoriasis Foundation. Benchmark survey on psoriasis and psoriatic arthritis summary of topline results. Portland (OR); 2003. Available at: http://www.psoriasis.org. Accessed July 6, 2004.
3. J.P. Callen, G.G. Krueger, M. Lebwohl, E.I. McBurney, P. Mease, and A. Menter American Academy of Dermatology consensus statement on psoriasis therapies J Am Acad Dermatol 49 2003 897 899
4. C.N. Ellis, T. Luger, D. Abeck, R. Allen, R.A.C. Graham-Brown, and Y. De Prost International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies Br J Dermatol 148 Suppl 63 2003 3 10
5. J.M. Hanifin, K.D. Cooper, V.C. Ho, S. Kang, B.R. Krafchik, and D.J. Margolis Guidelines of care for atopic dermatitis J Am Acad Dermatol 50 2004 391 404
6. National Council on Patient Information and Education. Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality. A national survey of consumers and health professionals. Bethesda (MD): National Council on Patient Information and Education; 2002. Available at: http://www.bemedwise.org/survey/final_survey.pdf. Accessed May 12, 2004.
7. Consumer Healthcare Products Association. Self-care in the new millennium. Washington (DC): Consumer Healthcare Products Association; 2001. Available at: http://www.chpa-info.org/web/press_room/statistics/PDFs/ CHPA_Final_Report_Revised_03_20.pdf. Accessed May 12, 2004.
8. Consumer Healthcare Products Association. OTC Retail Sales 1964-2002. Washington, DC; 2002. Available at: http://www.chpa-info.org/web/press_room/ statistics/otc_retail_sales.aspx. Accessed December 7, 2004.
9. National Center for Health Statistics. Health, United States, 2004 With Chartbook on Trends in the Health of Americans. Hyattsville (MD): National Center for Health Statistics; 2004
10. National Council on Patient Information and Education. Fact sheet. The use of over-the-counter medicines. Bethesda (MD): National Council on Patient Information and Education; 2003. Available at: http://www.bemedwise.org/ press_room/sep_2003_fact_otc.pdf. Accessed May 12, 2004.
11. A.H. Kaplan Fifty years of drug amendments revisited: in easy-to-swallow capsule form Food Drug Law J 50 1995 179 196
12. E.P. Brass, and M. Weintraub Label development and the label comprehension study for over-the-counter drugs Clin Pharm Ther 74 2003 406 412
13. E.P. Brass Changing the status of drugs from prescription to over-the-counter availability N Engl J Med 345 2001 810 816
14. National Consumers League Over the counter drugs study. Preliminary findings 2000 National Consumers League Washington (DC)
15. M.J. Shaw, A.M. Fendrick, R.L. Lane, S.A. Adlis, and N.J. Talley Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists Am J Gastroenterol 96 2001 673 676
16. D.G. Ferris, C. Dekle, and M.S. Litaker Women's use of over-the-counter antifungal medications for gynecologic symptoms J Fam Pract 42 1996 595 600
17. D.G. Ferris, P. Nyirjesy, J.D. Sobel, D. Soper, A. Pavletic, and M.S. Litaker Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis Obstet Gynecol 99 2002 419 425
18. S. Sihvo, R. Ahonen, H. Mikander, and E. Hemminki Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns Fam Pract 17 2000 145 149
19. P. Goustas, M.J. Cork, and D. Higson Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety J Dermatol Treat 14 2003 71 85
20. Pfizer Consumer Healthcare. Cortizone 10. Drug facts. 2000.
21. J.D. Guin Complications of topical hydrocortisone J Am Acad Dermatol 4 1981 417 422